YONGHUA ZHANG: Open Payments
NPI 1649828211 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 15 payments from 10 companies in 2025. Trend: 2023 $392 · 2024 $257 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 3 | $59 |
| ABBVIE INC. | 3 | $43 |
| Valinor Pharma, LLC | 2 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Neurelis, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: LUMRYZ, QULIPTA, MOVANTIK, HORIZANT, XTAMPZA, Sunosi, JOURNAVX, VALTOCO.
Industry payments across IN — which companies pay providers there.
